Welcome to our dedicated page for EASTMAN CHEMICAL CO SEC filings (Ticker: EMN), a comprehensive resource for investors and traders seeking official regulatory documents including 10-K annual reports, 10-Q quarterly earnings, 8-K material events, and insider trading forms.
Our SEC filing database is enhanced with expert analysis from Rhea-AI, providing insights into the potential impact of each filing on EASTMAN CHEMICAL CO's stock performance. Each filing includes a concise AI-generated summary, sentiment and impact scores, and end-of-day stock performance data showing the actual market reaction. Navigate easily through different filing types including 10-K annual reports, 10-Q quarterly reports, 8-K current reports, proxy statements (DEF 14A), and Form 4 insider trading disclosures.
Designed for fundamental investors and regulatory compliance professionals, our page simplifies access to critical SEC filings. By combining real-time EDGAR feed updates, Rhea-AI's analytical insights, and historical stock performance data, we provide comprehensive visibility into EASTMAN CHEMICAL CO's regulatory disclosures and financial reporting.
Gbadegesin Bosede Ikeolu reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical Company senior vice president, chief legal officer and corporate secretary Bosede Ikeolu Gbadegesin received equity awards as part of compensation. She was granted employee stock options for 33,223 shares on February 24, 2026, with one‑third becoming exercisable on February 24 of 2027, 2028 and 2029.
She also received 4,571 restricted stock units on the same date. Each unit represents the right to receive one share of common stock, and these RSUs vest and pay out in unrestricted shares on February 24, 2029, subject to continued employment.
Eastman Chemical Company executive Brad A. Lich reported equity awards granted as part of his compensation. On February 24, 2026, he acquired employee stock options for 63,123 shares of common stock at a grant price of $0 per option.
One-third of these options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029. He also received 8,684 restricted stock units, each representing one share of common stock, which will vest and pay out in unrestricted shares on February 24, 2029, subject to continued employment.
McLain William Thomas Jr. reported acquisition or exercise transactions in this Form 4 filing.
Eastman Chemical executive vice president and CFO William Thomas McLain Jr. reported equity awards consisting of 59,801 employee stock options and 8,227 restricted stock units, both granted at a price of $0 per unit.
One-third of the options become exercisable on February 24, 2027, February 24, 2028, and February 24, 2029. Each restricted stock unit represents the right to receive one share of common stock and will vest and pay out in unrestricted shares on February 24, 2029, subject to continued employment.
Eastman Chemical Company has issued $600,000,000 aggregate principal amount of 4.500% notes due February 20, 2031 in a public offering. The notes pay interest semi-annually on February 20 and August 20, starting August 20, 2026.
Before January 20, 2031, Eastman may redeem the notes at the greater of a make-whole amount based on the Treasury Rate plus 15 basis points or 100% of principal, plus accrued interest. On and after January 20, 2031, the notes are callable at 100% of principal, plus accrued interest.
The notes are senior unsecured obligations, ranking equally with other unsecured, unsubordinated Eastman debt and effectively junior to secured and subsidiary liabilities. If a change of control plus ratings downgrade occurs, holders can require Eastman to repurchase the notes at 101% of principal plus accrued interest. Net proceeds of approximately $593.7 million are earmarked for general corporate purposes, including working capital, capital expenditures, debt repayment and strategic initiatives.
Eastman Chemical Company executive Brad A. Lich, EVP & CCO, reported a tax-related share disposition on common stock. On February 18, 2026, 5,569 shares were withheld at $80.26 per share to cover tax obligations tied to the payout of performance shares for the 2023–2025 performance period. After this transaction, he directly owned 96,779 common shares, with additional indirect holdings through an ESOP and a 401(k) plan.
Eastman Chemical Company senior vice president Adrian James Holt reported a routine tax-withholding share disposition. On this Form 4, 588 shares of common stock were withheld at a price of $80.26 per share to cover tax obligations from the payout of performance shares for the 2023-2025 performance period. After this non-market transaction, Holt directly holds 1,709 shares of Eastman Chemical common stock.
Eastman Chemical Company executive reports tax-related share withholding. EVP, AFP, Mfg., WWEC & HSE Brian Travis Smith had 3,086 shares of common stock withheld at $80.26 per share on a tax-withholding disposition related to performance shares for the 2023–2025 performance period, leaving him with 24,235 directly owned shares.
Eastman Chemical Company senior vice president Julie A. McAlindon reported a tax-related share disposition involving company common stock. On February 18, 2026, 1,812 shares of common stock were withheld at $80.26 per share to satisfy tax obligations tied to a performance share payout for the 2023-2025 performance period.
After this withholding, McAlindon directly owned 18,199 shares of Eastman Chemical common stock. She also indirectly held 887 shares through an ESOP arrangement, reflecting separate plan-related ownership.
Eastman Chemical Company senior vice president Michelle H. Caveness had 528 shares of common stock withheld on February 18, 2026 to cover tax obligations tied to a performance share payout for the 2023–2025 period.
After this tax-withholding disposition, she directly owned 7,655 shares of Eastman Chemical common stock.
Eastman Chemical Company Controller and Chief Accounting Officer Michelle Renee Stewart reported a tax-related share disposition. On the reported date, 1,063 shares of common stock were withheld at a price of $80.26 per share to cover tax obligations tied to the payout of performance shares for the 2023-2025 performance period. After this withholding, her directly owned common stock holdings were 7,209 shares.